Pharmaceutical use of hexahydro-dibenzo[a,g]quinolizine compounds

US9737517B2 · kind B2 · utility

Assignee

• SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES · CN

Inventors

• Hong Liu · Shanghai, CN
• Xin XIE · Shanghai, CN
• Haifeng Sun · Suzhou, CN
• Jing Li · Lansdale, US
• Fei Zhao · Suzhou, CN
• Ying Chen · Los Angeles, US
• Zeng Li · Pudong New District, CN
• Yu Zhou · Shanghai, CN
• Hualiang Jiang · Shanghai, CN
• Kaixian Chen · Shanghai, CN

Key dates

• Filing date: May 4, 2014
• Grant date: Aug 22, 2017
• Expiry date: May 4, 2034

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Use of hexahydro-dibenzo[a,g]quinolizine compounds as shown in formula(I) in preparing a medicine for treating and/or preventing benign prostate hyperplasia diseases.